Genmab — August 2020
-
Jeps...vi må grave alt det positive frem...bare lidt..:-D
-
Flere spørgsmål til Q&A er meget velkommen.

-
God morgen.

-
Tak Doublo.

-
Lidt gentagelse: Approval of KdD in RRMM. https://www.onclive.com/view/fda-approves-daratumumab-plus-carfilzomib-dexamethasone-in-relapsed-refractory-myeloma
-
"Genmabs kursbevægelser skaber fortsat stor aktivitet". https://twitter.com/NordnetDK/status/1298572292516184064/photo/1
-
Tak for mange gode spørgsmål. De er stort set alle koncentreret omkring pipelinen. Jeg tager gerne i mod et par stykker omkring økonomi.

-
Her på falderebet.

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind